How Ozempic and other GLP-1 agonist drugs turn down ‘food noise’ and cravings – ABC News

How Ozempic and other GLP-1 agonist drugs turn down ‘food noise’ and cravings  ABC News

ITM targets US approval for radiopharmaceutical after Phase III readout

The company is planning an NDA submission for the neuroendocrine tumour-targeting ITM-11 later in 2025.

Can taking semaglutide before bariatric surgery boost weight loss? Here’s what scientists found – The Times of India

Can taking semaglutide before bariatric surgery boost weight loss? Here’s what scientists found  The Times of India

Recon: Judge bars compounders from making copies of Lilly’s weight loss drugs; PTAB invalidates two Moderna COVID vaccine patents – Regulatory Focus

Recon: Judge bars compounders from making copies of Lilly’s weight loss drugs; PTAB invalidates two Moderna…

You’ve Already Paid for Overpriced Weight-Loss Drugs – Jacobin magazine

You’ve Already Paid for Overpriced Weight-Loss Drugs  Jacobin magazine

What chunky dogs and obese people have in common — and what it tells us about weight loss – New York Post

What chunky dogs and obese people have in common — and what it tells us about…

Novo Nordisk to explore how GLP-1 drugs can help patients with addiction – Reuters

Novo Nordisk to explore how GLP-1 drugs can help patients with addiction  Reuters

Weight loss drug-makers are cutting prices – KSDK.com

Weight loss drug-makers are cutting prices  KSDK.com

Allosteric Bioscience, Inc. Licenses Sarcopenia (Muscle Loss) Prevention/Treatment Technology from Johns Hopkins University – Business Wire

Allosteric Bioscience, Inc. Licenses Sarcopenia (Muscle Loss) Prevention/Treatment Technology from Johns Hopkins University  Business Wire

Is Wegovy covered by Medicare? You may be able to get it, but only if you are in this specific situation – Marca English

Is Wegovy covered by Medicare? You may be able to get it, but only if you…